@article{f36bbed7b12e4742a15c1939e9fb9664,
title = "Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092)",
abstract = "To report the final data of a Phase I and II study (1839IL/0092) on the combination of an anti-epidermal growth factor receptor drug (gefitinib), infusional 5-fluorouracil, and preoperative radiotherapy in locally advanced, resectable rectal cancer.",
keywords = "Advanced Rectal Cancer, Preoperative chemioradiotherapy, Advanced Rectal Cancer, Preoperative chemioradiotherapy",
author = "Vincenzo Valentini and {De Paoli}, A and Gambacorta, {Maria Antonietta} and Giovanna Mantini and Carlo Ratto and Vecchio, {Fabio Maria} and Brunella Barbaro and R Innocente and Concettina Rossi and G Boz and Barba, {Maria Cristina} and Alessandro Frattegiani and M Lupattelli and Giovanni Doglietto",
year = "2008",
doi = "10.1016/j.ijrobp.2008.01.046",
language = "English",
volume = "72",
pages = "644--649",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",
}
